SCHEMBL5360595

SCHEMBL5360595

NCC1CCN(Cc2cccc(F)c2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
SIGMAR1 Q99720 4/20 0.54
BPTF Q12830 1/20 0.54
HSD17B10 Q99714 1/20 0.52
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
CXCR4 P61073 1/20 0.50
BCHE P06276 1/20 0.49
ACHE P22303 1/20 0.49
KDM4E B2RXH2 1/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12513635 0.85 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL30089449 0.84 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL6944257 0.84 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL2673348 0.84 CXCR4 (0.47) ALDH1A1SMN1; SMN2SIGMAR1BPTFCXCR4
SCHEMBL18105383 0.83 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL6524716 0.82 CXCR4 (0.58) ALDH1A1MEN1KMT2ADRD2DRD4
SCHEMBL29767413 0.82 MAPT (0.72) ALDH1A1SMN1; SMN2SIGMAR1DRD2DRD4
SCHEMBL16226986 0.82 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL8552073 0.81 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1
SCHEMBL12013927 0.81 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed